全文获取类型
收费全文 | 589篇 |
免费 | 6篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 58篇 |
妇产科学 | 27篇 |
基础医学 | 51篇 |
临床医学 | 52篇 |
内科学 | 276篇 |
皮肤病学 | 1篇 |
神经病学 | 20篇 |
特种医学 | 5篇 |
外科学 | 23篇 |
综合类 | 31篇 |
预防医学 | 25篇 |
眼科学 | 1篇 |
药学 | 23篇 |
中国医学 | 2篇 |
肿瘤学 | 1篇 |
出版年
2023年 | 6篇 |
2022年 | 19篇 |
2021年 | 30篇 |
2020年 | 9篇 |
2019年 | 59篇 |
2018年 | 25篇 |
2017年 | 18篇 |
2016年 | 7篇 |
2015年 | 15篇 |
2014年 | 12篇 |
2013年 | 16篇 |
2012年 | 5篇 |
2011年 | 13篇 |
2010年 | 7篇 |
2009年 | 7篇 |
2008年 | 8篇 |
2007年 | 10篇 |
2006年 | 5篇 |
2005年 | 6篇 |
2004年 | 6篇 |
2003年 | 2篇 |
2002年 | 1篇 |
2001年 | 5篇 |
2000年 | 5篇 |
1999年 | 2篇 |
1998年 | 2篇 |
1996年 | 1篇 |
1995年 | 1篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1985年 | 28篇 |
1984年 | 43篇 |
1983年 | 23篇 |
1982年 | 29篇 |
1981年 | 38篇 |
1980年 | 27篇 |
1979年 | 23篇 |
1978年 | 29篇 |
1977年 | 8篇 |
1976年 | 13篇 |
1975年 | 9篇 |
1974年 | 10篇 |
1973年 | 7篇 |
1968年 | 1篇 |
排序方式: 共有596条查询结果,搜索用时 15 毫秒
1.
2.
广泛性焦虑症与抑郁症患者免疫、内分泌及单胺递质的对照研究 总被引:7,自引:0,他引:7
目的探讨广泛性焦虑症(GAD)与抑郁症(MD)患者在免疫、内分泌和单胺递质方面的差异。方法 对30例GAD患者(焦虑症组)、38例MD患者(抑郁症组)在治疗(5-羟色胺再摄取抑制剂治疗6~8周)前后分别检测血清白细胞介素2(IL-2)、白细胞介素6(IL-6)、白细胞介素1β(IL-1β)、白细胞介素8(IL-8)、可溶性白细胞介素6受体(SIL-6R)、肿瘤坏死因子α(TNF-α)、皮质醇(CS)、促肾上腺皮质激素(ACTH)、肾上腺素(EPH)和去甲肾上腺素(NE)水平。选择30名年龄和性别与患者组相匹配的健康人为对照组。结果 (1)焦虑症组治疗前IL-8[(122±76)ng/L]、SIL-6R[(2 065±790)ng/L]水平均高于对照组(99±68)ng/L]、[(294±48)ng/L,IL-6水平为(1.6±0.7)ng/L,低于对照组[(5.3±2.7)ng/L],差异均有显著性意义(P<0.05);抑郁症组治疗前IL-2[(7.7±6.7)ng/L]、IL-8[(119±67)ng/L]、SIL-6R[(1308±371)ng/L]水平均高于对照组,差异均有显著性意义(均P<0.05)。经治疗后,焦虑症组IL-6[(4.3±1.2)ng/L]水平较治疗前升高,IL-8[(39±9)ng/L]水平较治疗前降低(P<0.05);抑郁症组IL-2[(2.4±1.2)ng/L]、IL-8[(47±15)ng/L]水平较治疗前降低(P<0.05);均接近于对照组水平(均P>0.05)。(2)焦虑症组治疗前ACIH[(49±28)ng/L]、EPH[(67±45)ng/ 相似文献
3.
4.
5.
6.
Nobuyuki Kamio Isao Kobayashi Masatomo Mori Teruo Uehara Hitoshi Fukuda Kazutoshi Tsuyusaki Yasuko Nakamua Setsuo Kobayashi 《Metabolism: clinical and experimental》1977,26(3):295-299
Serial measurements of serum triiodothyronine (T3), thyroxine (T4), thyrotropin (TSH), and 4-hr thyroidal 131I uptake were carried out in nine patients with subacute thyroiditis. In the acute phase, suppressed TSH and 131I uptake were observed simultaneously with the elevations of T3 and T4. Thyrotropin-releasing hormone (TRH) failed to increase TSH in all patients studied. The mean value of an increment in serum TSH was only 1.8 μU/ml during the recovery phase when 131I uptake was normal or hyper-normal. In addition, and elevated 131I uptake was not necessarily associated with an immediate increase in the serum T3 and T4. These observations suggest that the resumption of the iodide pump may be more important than an increment in TSH in producing normal or hypernormal 131I uptake during the recovery phase. There appears to be a dissociation between the reestablishment of 131I uptake and the resumption of the mechanism of hormonal synthesis and secretion in the thyroid. 相似文献
7.
Alan Chait Kurt Henze Theodore Mazzone Marty Jensen William Hammond 《Metabolism: clinical and experimental》1982,31(7):721-727
Circulating human monocytes and lymphocytes were isolated by counterflow and density gradient centrifugation. Binding and degradation of low density lipoprotein (LDL) occurred predominantly in monocytes and to a much lesser extent in lymphocytes. The findings are consistent with greater LDL receptor activity in freshly isolated monocytes than lymphocytes, in keeping with differences in other cell surface receptors between these two cell types. Therefore, when freshly isolated mixed mononuclear cells are used to study LDL receptor activity in vivo in humans, careful attention needs to be given to the proportions of monocytes and lymphocytes, or alternatively, relatively pure preparations of monocytes should be used. 相似文献
8.
9.
This study is an attempt to unify the evaluation of patients with well-differentiated thyroid cancer after ablative therapy. As such, serum thyroglobulin determinations on and off thyroid hormone (T4) therapy and iodine 131 total body scans were examined in 53 patient studies. No metastases were found in patients whose thyroglobulin value was undetectable (< 1 ng/ml). Values during T4 therapy that were detectable, even as low as 4.2 ng/ml, were occasionally associated with metastases. After T4 withdrawal, thyroglobulin value and scan were obtained. Neither metastasis nor clinically detectable cancer was found in patients whose thyroglobulin value was less than 10 ng/ml while off T4. Conversely, a value greater than 10 ng/ml was often associated with documented metastases even when the scan was negative. In summary, a thyroglobulin value less than 1 ng/ml during T4 therapy or less than 10 ng/ml off T4 therapy suggests successful therapy and a routine scan could be avoided unless clinically indicated. However, a value greater than 10 ng/ml suggests the presence of metastasis despite a negative scan. Thyroglobulin determination substantially improves the management of these patients. 相似文献
10.
Reza Heidari Akram Jamshidzadeh Nahid Keshavarz Negar Azarpira 《Scientia pharmaceutica》2015,83(1):143-158
Methimazole is the most widely prescribed antithyroid medication in humans. However, hepatotoxicity is a deleterious adverse effect associated with methimazole administration. No specific protective agent has been developed against this complication yet. This study was designed to investigate the role of taurine as a hepatoprotective agent against methimazole-induced liver injury in mice. Different reactive metabolites were proposed to be responsible for methimazole hepatotoxicity. Hence, methimazole-induced liver injury was investigated in intact and/or enzyme-induced animals in the current investigation. Animals were treated with methimazole (200 mg/kg, by gavage), and hepatic injury induced by this drug was investigated in intact and/or enzyme-induced groups. Markers such as lipid peroxidation, hepatic glutathione content, alanine aminotransferase (ALT) and alkaline phosphatase (ALP) in plasma, and histopathological changes in the liver of animals were monitored after drug administration. Methimazole caused liver injury as revealed by increased plasma ALT. Furthermore, a significant amount of lipid peroxidation was detected in the drug-treated animals, and hepatic glutathione reservoirs were depleted. Methimazole-induced hepatotoxicity was more severe in enzyme-induced mice. The above-mentioned alterations in hepatotoxicity markers were endorsed by significant histopathological changes in the liver. Taurine administration (1 g/kg, i.p.) effectively alleviated methimazole-induced liver injury in both intact and/or enzyme-induced animals. 相似文献